Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression

Journal of Affective Disorders

Volumn 120, Issue 1-3, 2010, Pages 86-93

  Tadić, André ^a   Helmreich, Isabella ^a   Mergl, Roland ^b   Hautzinger, Martin ^c   Kohnen, Ralf ^d   Henkel, Verena ^e   Hegerl, Ulrich ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d IMEREM Institute for Medical Research Management and Biometrics   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Depression; Early improvement; Outcome prediction; Pharmacotherapy; Primary care; Psychotherapy

Indexed keywords

PLACEBO; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEPRESSION; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; GUIDED IMAGERY; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SUBSYNDROMAL DEPRESSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SERTRALINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 71749109374     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.04.014     Document Type: Article

References (35)

1. Ackermann R.T., and Williams J.W. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J. Gen. Intern. Med. 17 (2002) 293-301
2. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 157 suppl. 4 (2000) 1-45
3. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ). Empfehlungen zur Therapie der Depression. Arzneiverord. Prax. 33 Sonderheft 1 (2006) 1-41
4. Backenstrass M., Frank A., Joest K., Hingman S., Mundt C., and Kronmuller K.T. A comparative study of nonspecific depressive symptoms and minor depression regarding functional impairment and associated characteristics in primary care. Comput. Psychiatry 47 (2006) 35-41
5. Bauer M., Bschor T., Pfennig A., Whybrow P.C., Angst J., Versiani M., Möller H.-J., and WFSBP Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J. Biol. Psychiatr. 8 (2007) 67-104
6. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
7. Hautzinger M. Kognitive Verhaltenstherapie bei Depressionen. 6th ed (2003), Beltz/PVU, Weinheim
8. Hegerl U., and Pfeiffer-Gerschel T. Das Kompetenznetz Depression, Suizidalität. Nervenheilkunde 24 (2005) 359-360
9. Hegerl U., Hautzinger M., Mergl R., Kohnen R., Schütze M., Scheunemann W., Allgaier A.-K., Coyne J., and Henkel V. Effects of pharmaco- and psychotherapy in depressed primary care patients. A randomized, controlled trial including a patient choice arm. Int. J. Neuropsychopharmacol (2009) 10.1017/S1461145709000224
10. Henkel V., Seemüller F., Obermeier M., Adli M., Bauer M., Mundt C., Brieger P., Laux G., Bender W., Heuser I., Zeiler J., Gaebel W., Mayr A., Möller H.-J., and Riedel M. Does early improvement triggered by antidepressants predict response/remission? - analysis of data from a naturalistic study on a large sample of inpatients with major depression. J. Affect. Disord (2008) 10.1016/j.jad.2008.10.011
11. Hermens M.L.M., van Hout H.P.J., Terluin B., van der Windt D.A.W.M., Beekman A.T.F., van Dyck R., and de Haan M. The prognosis of minor depression in the general population: a systematic review. Gen. Hosp. Psych. 26 (2004) 453-462
12. Hollon S.D., Jarrett R.B., Nierenberg A.A., Thase M.E., Trivedi M., and Rush A.J. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?. J. Clin. Psychiatry 66 (2005) 455-468
13. Katz M.M., Tekell J.L., Bowden C.L., Brannan S., Houston J.P., Berman N., and Frazer A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 29 (2004) 566-579
14. Keller F. Analyse von Längsschnittdaten: Auswertungsmöglichkeiten mit hierarchischen linearen Modellen. Z. Klin. Psychol. Psychother. 32 (2003) 51-61
15. Keller F., and Hautzinger M. Klassifikation von Verlaufskurven in der Depressionsbehandlung. Z. Klin. Psychol. Psychother. 36 (2007) 83-92
16. Leucht S., Shamsi S.A., Busch R., Kissling W., and Kane J.M. Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. Schizophr. Res. 101 (2008) 312-319
17. Lyness J.M., Moonseong H., Datto C.J., Ten Have T.R., Katz I.R., Drayer R., Reynolds C.F., Alexopoulos G.S., and Bruce M.L. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann. Intern. Med. 144 (2006) 496-504
18. National Institute for Health and Clinical Excellence. CG23 Depression - NICE Guideline 2004: Management of Depression in Primary and Secondary Care (2004). http://www.nice.org.uk/guidance/index.jsp?action=byID&o=10958 [http://www.nice.org.uk/guidance/index.jsp?action=byID&o=10958]
19. Nierenberg A.A., Farabaugh A.H., Alpert J.E., Gordon J., Worthington J.J., Rosenbaum J.F., and Fava M. Timing of onset of antidepressant response with fluoxetine treatment. Am. J. Psychiatry 157 (2000) 1423-1428
20. Papakostas G.I., Perlis R.H., Scalia M.J., Petersen T.J., and Fava M. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J. Clin. Psychopharmacol. 26 (2006) 56-60
21. Pincus H.A., Davis W.W., and McQueen L.E. 'Subthreshold' mental disorders: a review and synthesis of studies on minor depression and other 'brand names'. Br. J. Psychiatry 174 (1999) 288-296
22. Pollack M.H., Kornstein S.G., Spann M.E., Crits-Christoph P., Raskin J., and Russell J.M. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J. Psychiatr. Res. 42 (2008) 1176-1184
23. Posternak M.A., and Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J. Clin. Psychiatry 66 (2005) 148-158
24. Quitkin F.M., Rabkin J.G., Ross D., and Stewart J.W. Identification of true drug response to antidepressants. Use of pattern analysis. Arch. Gen. Psychiatry 41 (1984) 782-786
25. Rapaport M.H., Judd L.L., Schettler P.J., Yonders K.A., Thase M.E., Kupfer D.J., Frank E., Plewes J.M., Tollefson G.D., and Rush A.J. A descriptive analysis of minor depression. Am. J. Psychiatry 159 (2002) 637-643
26. Schouten H.J. Adaptive biased urn randomisation in small strata when blinding is impossible. Biometrics 51 (1995) 1529-1535
27. Stassen H.H., Angst J., Hell D., Scharfetter C., and Szegedi A. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. J. Clin. Psychiatry 68 (2007) 1195-1205
28. Szegedi A., Müller M.J., Anghelescu I., Klawe C., Kohnen R., and Benkert O. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J. Clin. Psychiatry 64 (2003) 413-420
29. Taylor M.J., Freemantle N., Geddes J.R., and Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch. Gen. Psychiatry 63 (2006) 1217-1223
30. Van H.L., Schoevers R.A., Kool S., Hendriksen M., Peen J., and Dekker J. Does early response predict outcome in psychotherapy and combined therapy for major depression?. J.Affect. Disord. 105 (2008) 261-265
31. van Calker D., Zobel I., Dykierek P., Deimel C.M., Kech S., Lieb K., Berger M., and Schramm E. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. J. Affect. Disord 114 (2008) 243-253
32. Wagner H.R., Burns B.J., Broadhead W.E., Yarnall K.S.H., Sigmon A., and Gaynes B.N. Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. Psychol. Med. 30 (2000) 1377-1390
33. Williams Jr. J.W., Kerber C.A., Mulrow C.D., Medina A., and Aguilar C. Depressive disorders in primary care: prevalence, functional disability, and identification. J. Gen. Intern. Med. 10 (1995) 7-12
34. In: Wittchen H.-U., and Pfister H. (Eds). DIA-X-Interview. Instruktionsmanual zur Durchführung von DIA-X Interviews (1997), Swets & Zeitlinger, Frankfurt am Main
35. World Health Organization. Composite International Diagnostic Interview (CIDI), Version 1.1 (1993), American Psychiatric Press, Washington DC